Asia Pacific Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Tuberculosis Diagnostics Market would witness market growth of 4.7% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Tuberculosis Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $312.6 million by 2031. The Japan market is registering a CAGR of 4.5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 5.9% during (2024 - 2031).

The market is driven by the need for timely and accurate disease detection, crucial for reducing transmission, initiating effective treatment, and improving patient outcomes. Early diagnosis of TB is essential because it allows for the prompt commencement of treatment, thereby reducing the likelihood of transmission to others and minimizing the risk of complications. This is particularly important in the case of drug-resistant TB, where delays in diagnosis can lead to the spread of more virulent strains that are harder to treat.

Moreover, the market is influenced by a variety of health initiatives and policies that are designed to alleviate the burden of TB, in addition to technological advancements. These initiatives have spurred investment in TB diagnostics from public health agencies and private sector companies, leading to the development of new tools and technologies designed to improve TB detection and management.

Free Valuable Insights: The Global Tuberculosis Diagnostics Market is Predict to reach USD 3.0 Billion by 2031, at a CAGR of 4.7%

In China, the demand for this is rising due to the country’s ongoing public health efforts to control TB, particularly in regions with high incidence rates and among vulnerable populations. The Chinese government has prioritized TB detection and treatment, especially in western provinces with less developed healthcare infrastructure. Implementing the National TB Control Program has increased the use of advanced diagnostic methods, including nucleic acid amplification tests (NAATs) and digital radiography, to ensure early and accurate diagnosis. Across the region, there is a clear trend towards adopting innovative diagnostic tools, supported by government initiatives, international funding, and public health campaigns to reduce TB incidence and mortality. Hence, the Asia Pacific region’s diverse and dynamic market is poised for continued growth as these nations intensify their efforts to combat TB and expand access to effective diagnostics.

Based on End Use, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Others. Based on Type, the market is segmented into Detection of Latent Infection (Skin Test & IGRA), Phage Assay, Detection of Drug Resistance (DST), Nucleic Acid Testing, Radiographic Method, Cytokine Detection Assay, Diagnostic Laboratory Methods, and Other Methods. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Abbott Laboratories
• Qiagen N.V
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• F.Hoffmann-La Roche Ltd.
• Hologic, Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• Bruker Corporation

Asia Pacific Tuberculosis Diagnostics Market Report Segmentation

By End Use

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

By Type

• Detection of Latent Infection (Skin Test & IGRA)
• Phage Assay
• Detection of Drug Resistance (DST)
• Nucleic Acid Testing
• Radiographic Method
• Cytokine Detection Assay
• Diagnostic Laboratory Methods
• Other Methods

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Tuberculosis Diagnostics Market, by End Use
1.4.2 Asia Pacific Tuberculosis Diagnostics Market, by Type
1.4.3 Asia Pacific Tuberculosis Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Tuberculosis Diagnostics Market by End Use
4.1 Asia Pacific Diagnostic Laboratories Market by Country
4.2 Asia Pacific Hospitals & Clinics Market by Country
4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Tuberculosis Diagnostics Market by Type
5.1 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country
5.2 Asia Pacific Phage Assay Market by Country
5.3 Asia Pacific Detection of Drug Resistance (DST) Market by Country
5.4 Asia Pacific Nucleic Acid Testing Market by Country
5.5 Asia Pacific Radiographic Method Market by Country
5.6 Asia Pacific Cytokine Detection Assay Market by Country
5.7 Asia Pacific Diagnostic Laboratory Methods Market by Country
5.8 Asia Pacific Other Methods Market by Country

Chapter 6. Asia Pacific Tuberculosis Diagnostics Market by Country
6.1 China Tuberculosis Diagnostics Market
6.1.1 China Tuberculosis Diagnostics Market by End Use
6.1.2 China Tuberculosis Diagnostics Market by Type
6.2 Japan Tuberculosis Diagnostics Market
6.2.1 Japan Tuberculosis Diagnostics Market by End Use
6.2.2 Japan Tuberculosis Diagnostics Market by Type
6.3 India Tuberculosis Diagnostics Market
6.3.1 India Tuberculosis Diagnostics Market by End Use
6.3.2 India Tuberculosis Diagnostics Market by Type
6.4 South Korea Tuberculosis Diagnostics Market
6.4.1 South Korea Tuberculosis Diagnostics Market by End Use
6.4.2 South Korea Tuberculosis Diagnostics Market by Type
6.5 Singapore Tuberculosis Diagnostics Market
6.5.1 Singapore Tuberculosis Diagnostics Market by End Use
6.5.2 Singapore Tuberculosis Diagnostics Market by Type
6.6 Malaysia Tuberculosis Diagnostics Market
6.6.1 Malaysia Tuberculosis Diagnostics Market by End Use
6.6.2 Malaysia Tuberculosis Diagnostics Market by Type
6.7 Rest of Asia Pacific Tuberculosis Diagnostics Market
6.7.1 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use
6.7.2 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Qiagen N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson, and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.6 SWOT Analysis
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.6 SWOT Analysis
7.6 Hologic, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Danaher Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 DiaSorin S.p.A.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Bruker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. Revvity, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis

TABLE 1 Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Phage Assay Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Phage Assay Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
TABLE 19 Asia Pacific Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
TABLE 20 Asia Pacific Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
TABLE 21 Asia Pacific Radiographic Method Market by Country, 2020 - 2023, USD Million
TABLE 22 Asia Pacific Radiographic Method Market by Country, 2024 - 2031, USD Million
TABLE 23 Asia Pacific Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
TABLE 24 Asia Pacific Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
TABLE 27 Asia Pacific Other Methods Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific Other Methods Market by Country, 2024 - 2031, USD Million
TABLE 29 Asia Pacific Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 30 Asia Pacific Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 31 China Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 32 China Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 33 China Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 34 China Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 35 China Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 36 China Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 37 Japan Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 38 Japan Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 39 Japan Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 40 Japan Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 41 Japan Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 42 Japan Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 43 India Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 44 India Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 45 India Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 46 India Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 47 India Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 48 India Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 49 South Korea Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 50 South Korea Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 51 South Korea Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 52 South Korea Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 53 South Korea Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 54 South Korea Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 55 Singapore Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 56 Singapore Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 57 Singapore Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 58 Singapore Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 59 Singapore Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 60 Singapore Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 61 Malaysia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 62 Malaysia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 63 Malaysia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 64 Malaysia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 65 Malaysia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 66 Malaysia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 67 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 68 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 69 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 70 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 71 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 72 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 73 Key Information – Abbott Laboratories
TABLE 74 Key Information – Qiagen N.V.
TABLE 75 Key Information – Thermo Fisher Scientific, Inc.
TABLE 76 Key Information – Becton, Dickinson and Company
TABLE 77 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 78 Key Information – Hologic, Inc.
TABLE 79 Key Information – Danaher Corporation
TABLE 80 Key Information – DiaSorin S.p.A.
TABLE 81 Key Information – Bruker Corporation
TABLE 82 Key Information – Revvity, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Tuberculosis Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Tuberculosis Diagnostics Market
FIG 5 Asia Pacific Tuberculosis Diagnostics Market share by End Use, 2023
FIG 6 Asia Pacific Tuberculosis Diagnostics Market share by End Use, 2031
FIG 7 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2031, USD Million
FIG 8 Asia Pacific Tuberculosis Diagnostics Market share by Type, 2023
FIG 9 Asia Pacific Tuberculosis Diagnostics Market share by Type, 2031
FIG 10 Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2031, USD Million
FIG 11 Asia Pacific Tuberculosis Diagnostics Market share by Country, 2023
FIG 12 Asia Pacific Tuberculosis Diagnostics Market share by Country, 2031
FIG 13 Asia Pacific Tuberculosis Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Abbott Laboratories
FIG 15 Swot Analysis: Qiagen N.V.
FIG 16 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 17 SWOT Analysis: Becton, Dickinson and company
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 Swot Analysis: Hologic, Inc.
FIG 20 SWOT Analysis: Danaher Corporation
FIG 21 SWOT Analysis: DiaSorin S.p.A.
FIG 22 Swot Analysis: Bruker Corporation
FIG 23 Swot Analysis: Revvity, Inc.